Engineers design artificial synapse for ‘brain-on-a-chip’ hardware
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
List view / Grid view
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
The ability to quantify the extent of kidney damage and predict the life remaining in the kidney is now possible using a computer model based on artificial intelligence...
Using data on genetic material, cell surface texture and typical facial features, researchers have utilised artificial intelligence methods to simulate rare disease models...
The emergence of big data, technological innovations and advancements in scientific research is set to be transformative for the pharmaceutical industry, providing faster access to insights that can drive more informed decision making and accelerate drug development. Dr Chris Barber, CEO of Lhasa Limited, looks at what is next for…
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
Scientists have used artificial intelligence capable of recognising the signatures of dementia two years before its onset...
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
Life Sciences and Healthcare supply chains need transformation to support the increasing cost pressures and consumer demands for new and more convenient, affordable care models…
A brain training game could help improve the memory of patients in the very earliest stages of dementia, suggests a study.
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
SmartAction and EndPoint Technologies have formed a strategic partnership to expand the availability of AI-powered customer technology.
Insurance companies are increasingly embracing innovative mobile solutions with the aim of helping their members live healthier lives and access quality care conveniently and efficiently.
Genpact’s new Pharmacovigilance Artificial Intelligence solution promises to transform drug safety data management and reporting…